Incidence of hypoglycemia with tight glycemic control protocols: a comparative study.

BACKGROUND Comparison of hypoglycemia incidence among tight glycemic control (TGC) protocols is a crucial aspect that has not been done in previous trials. This study compared the incidence of hypoglycemia using three TGC protocols in critically ill patients. METHODOLOGY This was a prospective study of 420 patients over 18 months. Patients were divided into three groups by TGC protocol: A (modified Leuven protocol), B (Georgia Hospital Association protocol, target blood glucose [BG] 80-110 mg/dL), and C (modified Georgia Hospital Association protocol, target BG 90-140 mg/dL). End points included differences in the incidence of first-degree hypoglycemia (BG <or= 60 mg/dL), second-degree hypoglycemia (BG <or= 40 mg/dL), and hyperglycemia (BG >or= 180 mg/dL). RESULTS A total of 34,497 BG samples were analyzed: group A, 11,202 (32.47%); group B, 9,627 (27.91%); and group C, 13,668 (39.62%). First-degree hypoglycemia was more frequent in group A (348 episodes [3.11%]) compared to group B (209 episodes [2.17%] [odds ratio (OR) 1.45, 95% confidence interval (CI) 1.25-1.172, P = 0.001]) and group C (266 episodes [1.95%] [OR 1.66, 95% CI 1.37-1.89, P = 0.001]). Second-degree hypoglycemia was more frequent in group A (131 episodes [1.17%]) compared to group B (62 episodes [0.64%] [OR 1.83, 95% CI 1.22-1.72, P = 0.001]) and group C (58 episodes [0.42%] [OR 2.77, 95% CI 2.04-3.79, P = 0.001]). No significant difference was found when groups B and C were compared (P = 0.10 and P = 0.06, respectively). Hyperglycemia was significantly more common in group A (2,175 episodes [19.42%]) compared to group B (1,333 episodes [13.83%] [OR 1.49, 95% CI 1.39-1.62, P = 0.001], but there was no significant difference compared to group C (2,560 episodes [18.73%] [P = 0.17]). CONCLUSIONS TGC protocols vary in their risk of inducing hypoglycemia. Whether this translates into differences in clinical outcomes such as mortality and adverse effects is still to be determined by future studies.

[1]  Bruce W Bode,et al.  Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy. , 2004, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[2]  Jaap E Tulleken,et al.  Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature , 2006, Critical care.

[3]  James Stephen Krinsley,et al.  Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. , 2003, Mayo Clinic proceedings.

[4]  Y. Arabi,et al.  Hypoglycemia with intensive insulin therapy in critically ill patients: Predisposing factors and association with mortality* , 2009, Critical care medicine.

[5]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[6]  J. Mechanick,et al.  Hypoglycemia in the intensive care unit , 2007, Current opinion in clinical nutrition and metabolic care.

[7]  Amy Callahan,et al.  Accuracy of bedside capillary blood glucose measurements in critically ill patients , 2006, Intensive Care Medicine.

[8]  G. Van den Berghe,et al.  Tight blood glucose control: What is the evidence? , 2007, Critical care medicine.

[9]  Mary T Korytkowski,et al.  American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[10]  G. Van den Berghe,et al.  Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. , 2003, Endocrinology.

[11]  Rattan Juneja,et al.  Computerized intensive insulin dosing can mitigate hypoglycemia and achieve tight glycemic control when glucose measurement is performed frequently and on time , 2009, Critical care.

[12]  P. Davidson,et al.  Improving Hyperglycemia Management in the Intensive Care Unit , 2006, The Diabetes educator.

[13]  Ziad A Memish,et al.  Intensive versus conventional insulin therapy: A randomized controlled trial in medical and surgical critically ill patients* , 2008, Critical care medicine.

[14]  A. Malhotra,et al.  Stress-induced hyperglycemia. , 2001, Critical care clinics.

[15]  Rolf Rossaint,et al.  Intensive insulin therapy and pentastarch resuscitation in severe sepsis. , 2008, The New England journal of medicine.

[16]  C. Wolf‐peeters,et al.  Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients , 2005, The Lancet.

[17]  G. Van den Berghe,et al.  Intensive insulin therapy in the medical ICU. , 2006, The New England journal of medicine.

[18]  Stephane Heritier,et al.  Intensive versus conventional glucose control in critically ill patients. , 2009, The New England journal of medicine.

[19]  Jeffrey B. Boord,et al.  Practical management of diabetes in critically ill patients. , 2001, American journal of respiratory and critical care medicine.

[20]  Ilse Vanhorebeek,et al.  Intensive insulin therapy protects the endothelium of critically ill patients. , 2005, The Journal of clinical investigation.